## SWK: Stanley Black & Decker, Inc. - XLI: Industrials

### Executive Summary

VALUE thesis: PEG 1.37 indicates fundamental undervaluation. Analyst consensus $92 (+18% upside). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($73.25)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Ethic Inc. Cuts Stock Position in Stanley Black & Decker, Inc. $SWK**
- Source: MarketBeat | 20260104T040841 | Somewhat-Bearish | Relevance: 99%
- Ethic Inc. significantly reduced its stake in Stanley Black & Decker, Inc. during the third quarter, selling 14,115 shares and retaining 14,774 shares valued at approximately $1.098 million. The article also highlights Stanley Black & Decker's dividend, high payout ratio, and a mixed outlook from analysts with a consensus "Hold" rating and a target price of $87.33. The company's stock performance, financials, and recent analyst activities are also detailed.

**2. Howmet Aerospace stock hits all-time high at 214.3 USD**
- Source: Investing.com | 20260105T150824 | Neutral | Relevance: 61%
- Howmet Aerospace Inc. (HWM) reached an all-time high of $214.3 USD, reflecting strong investor confidence and an 88.25% 1-year price return. The company boasts a perfect Piotroski Score of 9 and "GREAT" financial health, despite appearing overvalued by InvestingPro metrics. This surge is further bolstered by the recent acquisition of Stanley Black & Decker's Consolidated Aerospace Manufacturing business and positive analyst sentiment, with targets up to $250.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-05 | UBS | $98 | $105 | -7% |
| 2025-12-23 | Baird | $85 | $75 | +13% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-05 | UBS | main | Buy |
| 2025-12-23 | Baird | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 9 ($0.07M) |
| Sells | 7 ($0.85M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (-2.3%)
- Capital Research Glo: 8.2% (+0.9%)
- Blackrock Inc.: 6.7% (-11.1%)
- Price (T.Rowe) Assoc: 6.3% (-19.4%)
- State Street Corpora: 5.6% (-7.6%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +2.0% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.37 suggests fair value with growth premium. Forward P/E 13.5x attractive for 26% earnings growth. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.0B |
| Beta | 1.20 |
| 52W Range | $53.91 - $91.06 |
| Short Interest | 4.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.37 |
| Forward P/E | 13.5 |
| Current P/E | 17.0 |
| YoY Growth | 25.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 1.7% to 3.7% (+2.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.3pp (needs >4.0% for momentum thesis). MRS_5 at 1.9% confirms short-term momentum alignment. AM_20 at 3.8% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.70% (CS: 78) | Neutral |
| RSI_14 | 64.7 | Neutral |
| MACD Histogram | 0.10 | Bullish |
| vs SMA20 | 1.038x | Above |
| vs SMA50 | 1.091x | Above |
| vs SMA200 | 1.105x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $77.25
- **Stop Loss:** $73.25 (5.2% risk)
- **Target:** $85.25 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 345
- **Position Value:** $26,651.25
- **Portfolio %:** 26.65%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-02-05 (Est: $1.28)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.19 | $1.43 | +20.0% |
| 2025Q2 | $0.42 | $1.08 | +159.7% |
| 2025Q1 | $0.66 | $0.75 | +13.9% |
| 2024Q4 | $1.27 | $1.49 | +17.3% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*